NCT00656006View on ClinicalTrials.gov

A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Chronic Hepatitis C
Interventions
DRUG

Albuferon

DRUG

Ribavirin

Trial Locations (6)

T2N 4N1

University of Calgary, Calgary

T6G 2X8

University of Alberta, Edmonton

V5Z 3P1

University of British Columbia, Vancouver

R3E 2P4

University of Manitoba, Winnipeg

N6A 5A5

University of Western Ontario, London

S7N 0W8

University of Saskatchewan, Saskatoon

Sponsors
All Listed Sponsors
lead

Human Genome Sciences Inc.

INDUSTRY